AVKARE LLC has recalled 1,237 cartons of AvKARE brand Glycopyrrolate Tablets, USP (1 mg), because the tablets failed to meet approved quality standards for unknown impurities. These prescription tablets, dispensed in unit-dose cartons, were distributed nationwide to pharmacies. No injuries or illnesses have been reported to date in connection with this recall.
The medication was found to contain levels of unknown impurities or degradation products that exceed approved safety and quality specifications. While no incidents have occurred, these impurities could potentially impact the effectiveness or safety of the drug over time.
You have 2 options:
Manufactured for: AvKARE Pulaski, TN 38478; Rx Only
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.